Adrenergic beta3-Agonists [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Adrenergic beta3-Agonists [MoA] includes 2 drugs with a combined 25,187 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
25,187
Combined Reports
All Adrenergic beta3-Agonists [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| MIRABEGRON | MIRABEGRON | 20,618 | 1,338 | 2,589 | 6.5% |
| VIBEGRON | GEMTESA | 4,569 | 139 | 259 | 3.0% |
Common Side Effects in Adrenergic beta3-Agonists [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Drug ineffective | 4,883 | 488 |
| Off label use | 1,761 | 723 |
| Headache | 1,506 | 326 |
| Intentional product misuse | 1,416 | 18 |
| Dizziness | 1,400 | 443 |
| Blood pressure increased | 1,147 | 2 |
| Diarrhoea | 1,136 | 408 |
| Dry mouth | 1,134 | 457 |
| Hypertension | 1,085 | 491 |
| Therapeutic product effect incomplete | 1,066 | 275 |